OK Biotech Co., Ltd. (TPE:4155)

Market Cap	2.06B -9.4%
Revenue (ttm)	1.53B -11.7%
Net Income	113.01M +36.7%
EPS	0.78 +37.7%
Shares Out	141.12M
PE Ratio	18.62
Forward PE	n/a
Dividend	0.30 (2.01%)
Ex-Dividend Date	Jul 4, 2025

Volume	135,013
Open	14.45
Previous Close	14.60
Day's Range	14.30 - 14.60
52-Week Range	12.85 - 17.25
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About OK Biotech

OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OK...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4155

Financial Performance

In 2025, OK Biotech's revenue was 1.56 billion, a decrease of -6.81% compared to the previous year's 1.67 billion. Earnings were 82.45 million, a decrease of -12.26%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error